Treatment results and prognostic factors of pediatric neuroblastoma: A retrospective study

International Archives of Medicine

Volumn 3, Issue 1, 2010, Pages

  El Sayed, Mohamed I ^a   Ali, Amany M ^a   Sayed, Heba A ^a   Zaky, Eman M ^b  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ADRENALECTOMY; ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BONE METASTASIS; BONE SCINTISCANNING; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEST INFECTION; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG TOLERABILITY; EGYPT; EVENT FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; INFANT; LEUKOPENIA; LIVER METASTASIS; LUNG FIBROSIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEPHRECTOMY; NEUROBLASTOMA; ONCOGENE C MYB; OTOTOXICITY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIMARY TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEPTICEMIA; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 78650431065     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-3-37     Document Type: Article

References (29)

1. Neuroblastoma: A clinical challenge and biologic puzzle. KK Matthay, CA Cancer J Clin 1995 45 179 192 10.3322/canjclin.45.3.179 7743421
2. Neuroblastoma: Biology and therapy. KK Matthay, Oncology 1997 11 1857 1866 9436190
3. Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. F Berthold B Hero B Kremens, et al. Cancer Lett 2003 197 11 7 10.1016/S0304-3835(03)00076-4 12880954
4. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. ML Schmidt JN Lukens RC Seeger, et al. J Clin Oncol 2000 18 1260 1268 10715296
5. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group. S Goto S Umehara RB Gerbing, et al. Cancer 2001 92 2699 2708 10.1002/1097-0142(20011115)92:10<2699::AID-CNCR16243.0.CO;2-A 11745206
6. Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastoma. KK Matthay, Pediatr Transplant 1999 3 72 77 10.1034/j.1399-3046.1999.00070.x 10587975
7. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. GM Brodeur J Pritchard F Berthold, et al. J Clin Oncol 1993 11 1466 1477 8336186
8. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a Children's Cancer Group study. CA Perez KK Matthay JB Atkinson, et al. J Clin Oncol 2000 18 18 26 10623689
9. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. KK Matthay JG Villablanca RC Seeger, et al. N Engl J Med 1999 341 1165 1173 10.1056/NEJM199910143411601 10519894
10. Imact of radiotherapy for high risk neuroblastoma: A Children's Cancer Group Study. DA Haas-Kogan PS Swift M Selch GM Haase RC Seeger RB Gerbing DO Stram KK Matthay, Int J Radiation Oncology Biol Phys 2003 56 1 28 39 10.1016/S0360-3016(02)04506-6
11. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children 1 year with residual local disease. T Simon B Hero R Bongartz M Schmidt RP Müller F Berthold, Strahlenther Onkol 2006 182 389 94 10.1007/s00066-006-1498-8 16826357
12. Neuroblastoma in childhood: review and radiological findings. G Papaioannou K McHugh, Cancer Imaging 2005 5 1 116 127 10.1102/1470-7330.2005. 0104 16305949
13. Birth Characteristics and Risk of Neuroblastoma in Young Children. KY Urayama J Von Behren P Reynolds, American Journal of Epidemiology 2007 165 5 486 95 10.1093/aje/kwk041 17164463
14. Neuroblastoma in Turkish children: experience of a single center. GB Aydn MT Kutluk B Yalçn M Büyükpamukçu G Kale A Varan C Akyüz ME Senocak N Büyükpamukçu, J Pediatr Hematol Oncol 2009 31 7 471 80 10.1097/MPH.0b013e3181a6dea4 19564739
15. Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany. J Schüz U Kaletsch R Meinert P Kaatsch C Spix J Michaelis, J Clin Epidemiology 2001 54 702 709
16. Epidemiological and some clinical characteristics of neuroblastoma in Mexican children (1996-2005). S Jurez-Ocãa V Palma-Padilla G Gonzlez-Miranda AG Siordia-Reyes E Lápez-Aguilar M Aguilar- Martínez JM Mejía-Aranguré R Carreán-Cruz ME Rendán-Macías A Fajardo-Gutiérrez, BMC Cancer 2009 9 266 19650918
17. Neuroblastoma in childhood: review and radiological findings. G Papaioannou K McHugh, Cancer Imaging 2005 5 1 116 127 10.1102/1470-7330.2005. 0104 16305949
18. Customized Oligonucleotide Microarray Gene Expression-Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification. A Oberthuer F Berthold P Warnat B Hero Y Kahlert R Spitz K Ernestus R König S Haas R Eils M Schwab B Brors F Westermann M Fischer, Journal of Clinical Oncology 2006 24 31 5070 5078 10.1200/JCO.2006.06.1879 17075126
19. Pattern and outcome of neuroblastoma: A 10 year study. P Kusumakumary TV Ajithkumar K Ratheesan VG Chellam MK Nair, Indian Pediatrics 1998 35 223 229 9707875
20. Age at Diagnosis and Prognosis in Children With Neuroblastoma. AE Evans GJ D'Angio, Journal of Clinical Oncology 2005 23 27 6443 6444 10.1200/JCO.2005.05.005 16116157
21. Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors. A Garaventa L Boni MS Lo Piccolo GP Tonini C Gambini A Mancini L Tonegatti M Carli LC di Montezemolo A Di Cataldo F Casale K Mazzocco G Cecchetto A Rizzo B De Bernardi, Annals of Oncology 2002 13 6 956 964 10.1093/annonc/mdf165 12123342
22. Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group. WB London RP Castleberry KK Matthay AT Look RC Seeger H Shimada P Thorner G Brodeur JM Maris CP Reynolds SL Cohn, Journal of Clinical Oncology 2005 23 27 6443 6444 10.1200/JCO.2005.05. 571 16116157
23. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: A Children's Cancer Group Study. ML Schmidt A Lal R Seeger, et al. J Clin Oncol 2005 23 6474 6480 10.1200/JCO.2005.05.183 16116154
24. Neuroblastoma. S Shusterman RE George, Oncology of infancy and childhood, Orkin SH, Fisher DE, Look AT, Lux SE, Ginsburg D, Nathan DG, 2009 Chapter 14 509 540
25. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study. LC Bowman RP Castleberry A Cantor, et al. J Natl Cancer Inst 1997 89 373 380 10.1093/jnci/89.5.373 9060959
26. Advances in the Diagnosis and Treatment of Neuroblastoma. JL Weinstein HM Katzenstein SL Cohn, The Oncologist 2003 8 3 278 292 10.1634/theoncologist.8-3- 278 12773750
27. Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by MYCN Status and Tumor Cell Ploidy. R Bagatell P Rumcheva WB London SL Cohn AT Look GM Brodeur C Frantz V Joshi P Thorner PV Rao R Castleberry C Laura LC Bowman, Journal of Clinical Oncology 2005 23 34 8819 8827 10.1200/JCO.2004.00.2931 16314642
28. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. RP Castleberry LE Kun JJ Shuster, et al. J Clin Oncol 1991 9 789 95 2016621
29. Response and toxicity to a dose-intensive multi-agent chemotherapy induction regimen for high risk neuroblastoma (HR-NB): A Children's Oncology Group (COG A3973) study. SG Kreissman JG Villablanca L Diller WB London JM Maris JR Park CP Reynolds D von Allmen SL Cohn KK Matthay, Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I 2007 25 18S 9505